Try our corporate solution for free!
(212) 419-8286

Expected consequences of moving US pharma manufacturing to the US, by gender

This statistic shows the results of a survey conducted in the United States in February 2017, by gender. U.S. adults were given a list of 11 options and asked to select which consequences they would expect if U.S. pharma companies were forced to move their manufacturing from abroad back to the U.S. About 42 percent of female respondents said that they would expect higher drug prices, while 41 percent of male respondents indicated the same.

Opinions on consequences in case U.S. pharma companies would be forced to manufacture in-country as of 2017, by gender

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in

Release date

February 2017


United States

Survey time period

February 6 to 8, 2017

Number of respondents

1,029 respondents

Age group

18 years and older

Method of interview

Online survey

Supplementary notes

Original question: "A lot of US pharma companies manufacture abroad. Which consequences do you expect in case pharma companies were forced to manufacture in the US?" (multiple pick)

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Pharmaceutical industry in Norway "

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.